Glucotrack, Inc.

For the period ended Dec 31, 2024. Filed Mar 31, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 31, 2025

GCTK$1.39-32.2%Stored close · as of Oct 29, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	GLUCOTRACK, INC.
Date:	March 31, 2025	By:	/s/ Paul Goode
	Name:	Paul Goode
	Title:	Chief Executive Officer
		(Principal Executive Officer)

Date:	March 31, 2025	By:	/s/ Peter Wulff
	Name:	Peter Wulff
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Erin Carter
Signature	Title	Date
/s/ Paul Goode	Chief Executive Officer and Director	March 31, 2025
Paul Goode	(Principal Executive Officer)
/s/ Peter Wulff	Chief Financial Officer	March 31, 2025
Peter Wulff	(Principal Financial and Accounting Officer)
/s/ Erin Carter	Director	March 31, 2025
/s/ Luis Malave	Director	March 31, 2025
Luis Malave
/s/ Robert Fischell	Director	March 31, 2025
Dr. Robert Fischell
/s/ Andrew Balo	Director	March 31, 2025
Andrew Balo
/s/ Allen Danzig	Director	March 31, 2025
Allen Danzig
/s/ John Ballantyne	Director	March 31, 2025
John Ballantyne

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.